🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/12/2000 | 47,26 | 48,89 | 46,32 | 48,19 | +0,98% | 5,45% | 70.452 |
| 14/12/2000 | 48,19 | 49,83 | 47,26 | 47,72 | -1,45% | 5,34% | 43.174 |
| 13/12/2000 | 48,89 | 51,93 | 48,19 | 48,42 | +0,49% | 7,66% | 226.531 |
| 12/12/2000 | 50,30 | 50,53 | 48,19 | 48,19 | -4,19% | 4,65% | 100.749 |
| 11/12/2000 | 53,57 | 53,57 | 49,59 | 50,30 | -4,87% | 7,42% | 27.732 |
| 08/12/2000 | 48,72 | 53,57 | 48,19 | 52,87 | +8,65% | 11,04% | 75.822 |
| 07/12/2000 | 46,79 | 49,59 | 46,79 | 48,66 | +2,46% | 6,00% | 51.189 |
| 06/12/2000 | 47,49 | 49,59 | 46,55 | 47,49 | -3,33% | 6,40% | 34.090 |
| 05/12/2000 | 47,72 | 50,06 | 46,79 | 49,13 | +2,94% | 6,86% | 56.987 |
| 04/12/2000 | 47,49 | 47,96 | 45,85 | 47,72 | -1,45% | 4,43% | 55.063 |
| 01/12/2000 | 47,02 | 49,83 | 47,02 | 48,42 | +2,99% | 5,97% | 36.442 |
| 30/11/2000 | 49,95 | 50,53 | 46,55 | 47,02 | -7,37% | 7,96% | 59.204 |
| 29/11/2000 | 49,24 | 53,10 | 49,13 | 50,76 | +3,83% | 8,08% | 66.337 |
| 28/11/2000 | 52,64 | 52,87 | 48,89 | 48,89 | -7,52% | 7,56% | 62.116 |
| 27/11/2000 | 53,81 | 55,68 | 51,47 | 52,87 | -0,44% | 7,83% | 55.250 |
| 24/11/2000 | 47,72 | 53,34 | 46,32 | 53,10 | +10,73% | 14,71% | 50.762 |
| 22/11/2000 | 48,72 | 49,59 | 46,79 | 47,96 | -3,30% | 5,76% | 80.097 |
| 21/11/2000 | 49,13 | 50,06 | 48,42 | 49,59 | -0,93% | 3,33% | 70.238 |
| 20/11/2000 | 51,93 | 52,40 | 48,66 | 50,06 | -4,46% | 7,21% | 77.345 |
| 17/11/2000 | 54,04 | 55,44 | 51,93 | 52,40 | +2,75% | 6,49% | 44.510 |
| 16/11/2000 | 52,64 | 56,14 | 51,00 | 51,00 | -6,03% | 9,78% | 38.953 |
| 15/11/2000 | 49,89 | 56,38 | 49,59 | 54,27 | +3,57% | 13,60% | 53.941 |
| 14/11/2000 | 50,53 | 53,34 | 49,13 | 52,40 | +4,19% | 8,33% | 74.433 |
| 13/11/2000 | 47,72 | 52,17 | 45,62 | 50,30 | -4,02% | 13,73% | 111.783 |
| 10/11/2000 | 56,61 | 56,85 | 52,40 | 52,40 | -8,20% | 7,85% | 57.788 |
| 09/11/2000 | 55,68 | 58,25 | 55,21 | 57,08 | +0,83% | 5,46% | 116.859 |
| 08/11/2000 | 58,72 | 58,72 | 56,61 | 56,61 | -2,02% | 3,59% | 44.644 |
| 07/11/2000 | 59,19 | 59,89 | 56,38 | 57,78 | -2,95% | 5,93% | 47.262 |
| 06/11/2000 | 58,31 | 60,36 | 57,55 | 59,54 | -0,59% | 4,81% | 64.147 |
| 03/11/2000 | 56,38 | 59,89 | 55,44 | 59,89 | +4,07% | 7,88% | 71.440 |